MedPath

Fujian Medical University Union Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
http://www.fjxiehe.com/

Clinical Trials

74

Active:3
Completed:9

Trial Phases

5 Phases

Phase 1:1
Phase 2:17
Phase 3:5
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (52 trials with phase data)• Click on a phase to view related trials

Not Applicable
23 (44.2%)
Phase 2
17 (32.7%)
Phase 4
6 (11.5%)
Phase 3
5 (9.6%)
Phase 1
1 (1.9%)

Effects of Different Preoperative Oral Rehydration Protocols in Undergoing Thoracoscopic Radical Lung Cancer Surgery

Not yet recruiting
Conditions
Postoperative Delirium
First Posted Date
2025-06-29
Last Posted Date
2025-06-29
Lead Sponsor
Fujian Medical University Union Hospital
Target Recruit Count
420
Registration Number
NCT07042503

Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study

Not Applicable
Active, not recruiting
Conditions
Breast Cancer Surgery
Neoadjuvant Therapy
Sentinel Lymph Node Biopsy (SLNB)
Interventions
Drug: carbon suspension
First Posted Date
2025-06-22
Last Posted Date
2025-06-22
Lead Sponsor
Fujian Medical University Union Hospital
Target Recruit Count
175
Registration Number
NCT07032220
Locations
🇨🇳

Study Officials, Fuzhou, Fujian, China

Comparison of Cardiovascular Risks Between Hip Fracture Surgery With Continued DAPT(Dual Antiplatelet Therapy ) Within 6 Weeks vs After 6 Weeks Post-PCI(Percutaneous Coronary Intervention): A Prospective Observational Cohort Study

Not yet recruiting
Conditions
PCI Patients
DAPT(Dual Antiplatelet Therapy)
Hip Fracture Surgeries
First Posted Date
2025-06-17
Last Posted Date
2025-06-17
Lead Sponsor
Fujian Medical University Union Hospital
Target Recruit Count
50
Registration Number
NCT07024446

Tubeless Anesthesia in Preventing Lung Complications in Patients Undergoing Surgery for Early-Stage Lung Cancer

Not Applicable
Recruiting
Conditions
Lung Cancer Patients
First Posted Date
2025-06-17
Last Posted Date
2025-06-17
Lead Sponsor
Fujian Medical University Union Hospital
Target Recruit Count
224
Registration Number
NCT07024433
Locations
🇨🇳

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

Phase 2
Conditions
Small-cell Lung Cancer
First Posted Date
2025-03-25
Last Posted Date
2025-03-25
Lead Sponsor
Fujian Medical University Union Hospital
Target Recruit Count
35
Registration Number
NCT06816966
Locations
🇨🇳

Fujian Medical University Union Hospital,, Fuzhou, Fujian, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath